Clinical Trial

Microplastics in Brain Hematomas and Neurological Outcomes After Intracerebral Hemorrhage

Study acronym: PARTENOPE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This observational study investigates the presence of micro- and nanoplastics in surgically removed intracerebral hematomas and their association with neurological outcomes in patients with spontaneous intracerebral hemorrhage. Microplastics have recently been identified in human tissues and are increasingly recognized as potential contributors to inflammation and vascular dysfunction. However, their role in cerebrovascular diseases, particularly intracerebral hemorrhage, remains unknown. Patients undergoing surgical hematoma evacuation will be enrolled. Brain tissue and blood samples will be analyzed using advanced spectroscopic and imaging techniques to detect and characterize micro- and nanoplastics. The study aims to evaluate whether the presence of these particles is associated with increased inflammation, worse neurological outcomes, and higher risk of adverse cerebrovascular events. This research may provide novel insights into the impact of environmental pollutants on brain vascular disease and patient prognosis.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-06-03
Trial Details
NCT Number NCT07580326
Lead Sponsor University of Campania Luigi Vanvitelli
Collaborators: Federico II University, IRCCS Multimedica
Conditions Intracerebral Hemorrhage, Brain Hematoma
Enrollment 150 participants
Start Date 2024-06-01
Primary Completion 2025-01-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-02